Grace Anne Dorney Koppel, wife of Ted, the longtime anchor of ABC News' Nightline, has been bringing more awareness to COPD, ...
The FDA just approved the first once-daily oral PCSK9 pill, and five major stocks now sit in the crosshairs. Not all of them ...
Kerendia will become available to English patients with chronic heart failure with preserved or mildly reduced ejection ...
Pharmaceutical Technology on MSN
MSD wins FDA approval for cholesterol pill to help plug Keytruda void
MSD has outpaced rivals to market the first PCSK9 inhibitor in pill form for patients with high cholesterol.
Clinicians report that early AKT inhibition side effects are manageable, allowing four out of five patients to maintain ...
Healthy eaters who never smoked are getting lung cancer—and scientists think pesticides on produce may be why.
The trial reported that none of the 13 patients treated so far have experienced serious adverse events related to ENV-105.
Harris Oakmark recently released its second-quarter 2026 investor letter for the “Oakmark Global Fund”. A copy of the letter ...
Background and aims Restoration of intestinal barrier integrity and function in inflammatory bowel disease (IBD) has been ...
A new startup is making a bold move in the world of obesity drug development: It’s not working with the GLP-1 target that has ...
J&J’s shares ticked down as oncology sales missed expectations. Elsewhere, AstraZeneca bet $600 million on a lung cancer drug and a pair of biotechs snagged two of the year’s top venture rounds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results